DarioHealthDRIO +7.85%58 Gross Margin % is 57.31% as of Mar. 2026, which is 83% above its 10-year median of 31.29. GuruFocus rates DRIO with a GF Score™ of 58/100 and a GF Value™ of $7.09 (Fairly Valued). The stock has 4 warning signs investors should review. Among 630 Healthcare Providers & Services companies, DarioHealth ranks better than 67.14% on this metric.
The historical rank and industry rank for DarioHealth's Gross Margin % or its related term are showing as below:
DRIO'
s Gross Margin % Range Over the Past 10 Years
Min: -20.01 Med: 31.29 Max: 56.64
Current: 56.55
During the past 13 years, the highestGross Margin % of DarioHealth was 56.64%. The lowest was -20.01%. And the median was 31.29%.
DRIO's Gross Margin % is ranked better than 67.14% of 630
companies
in the Healthcare Providers & Services industry
Industry Median: 40.075
vs DRIO: 56.55
DarioHealth had a gross margin of 57.31% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for DarioHealth was 16.40% per year.
DarioHealth (NAS:DRIO) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
DarioHealth had a gross margin of 57.31% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
DarioHealth Gross Margin % Related Terms
DarioHealth Gross Margin % Historical Data
* Premium members only.
The historical data trend for DarioHealth's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DRIO vs BEAT, ONMD, CRVW: Gross Margin % Comparison
For the Health Information Services subindustry, DarioHealth's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DarioHealth Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DarioHealth's Gross Margin % distribution charts can be found below:
* The bar in red indicates where DarioHealth's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
DarioHealth (DRIO) has a Gross Margin % of 57.31% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on DarioHealth and its competitors. This is 83% above median its historical median of 31.29. According to the industry distribution chart, DarioHealth ranks #207 out of 630 companies in the Healthcare Providers & Services industry, placing it in the top 32.9%.
Is DarioHealth's Gross Margin % too high?
DarioHealth's current Gross Margin % of 57.31% is 83% above median its 10-year median of 31.29. The Healthcare Providers & Services industry median Gross Margin % is 40.08. DarioHealth's value of 57.31% is 43% above this industry median. Based on the distribution chart, DarioHealth ranks #207 out of 630 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, DarioHealth has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DarioHealth's Gross Margin % compare to BEAT and ONMD?
According to the Healthcare Providers & Services industry distribution chart, DarioHealth ranks #207 out of 630 companies for Gross Margin %. This puts DarioHealth in the upper half of its industry. The industry median Gross Margin % is 40.08. DarioHealth's value of 57.31% is 43% above this benchmark. While the company's 10-year median is 31.29 vs. the industry median of 40.08, DarioHealth has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.08, based on 630 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DarioHealth's current Gross Margin % of 57.31% is 43% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on DarioHealth and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DarioHealth's current Gross Margin % is 57.31%, which is 83% above median its own 10-year median of 31.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DarioHealth stock overvalued right now?
Based on GuruFocus' analysis, DarioHealth (DRIO) is currently considered Fairly Valued. The stock's GF Value™ is $7.09, compared to a current price of $7.26 — trading 2.3% above its estimated fair value. The current Gross Margin % is 57.31%, which is 83% above median its 10-year median of 31.29 and 43% above the Healthcare Providers & Services industry median of 40.08. DarioHealth's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For DarioHealth (DRIO), the current Gross Margin % is 57.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DarioHealth (DRIO) Overvalued in 2026?
Based on GuruFocus' analysis, DarioHealth stock appears to be overvalued.
The current stock price of $7.26 is trading 2.3% above its estimated GF Value™ of $7.09.
GuruFocus considers DarioHealth to be Fairly Valued.
Key valuation signals for DRIO:
Gross Margin %: 57.31% (83% above median its 10-year median of 31.29)
GF Value™: $7.09 vs. price of $7.26 (2.3% above fair value)
Industry Position: 43% above the Healthcare Providers & Services median (#207 of 630)
No single metric tells the full story. See the DRIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
58GF Score
Get the complete analysis for DRIO
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DRIO has been successfully added to your 
